Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L287258-5mg | 5mg | In stock | $107.90 | |
L287258-10mg | 10mg | In stock | $165.90 | |
L287258-25mg | 25mg | In stock | $371.90 | |
L287258-50mg | 50mg | In stock | $711.90 | |
L287258-100mg | 100mg | In stock | $1,280.90 | |
L287258-250mg | 250mg | In stock | $2,881.90 |
RNA binding protein Lin28 inhibitor; promotes mESC differentiation; also bromodomain inhibitor
Synonyms | Lin28 1632 | Lin-28 1632 | N-methyl-N-[3-(3-methyl-1,2,4-triazolo[4,3-b]-pyridazin-6-yl)phenyl]acetamide | N-Methyl-N-[3-(3-methyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]acetamide | CCG-42206 | DTXSID20371981 | HMS1448E05 | Lin281632 | Lin-281632 | WP |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | RNA binding protein Lin28 inhibitor (IC50= 8μM). Blocks binding of Lin28 to let-7 pre-micro RNA. Inhibits stemness and induces differentiation of murine ESCs. Increaseslet-7miRNA and suppresses PD-L1 expression in multiple human cancer cell lines. Inhibit |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | Product Describtion: Lin28-let-7 antagonist 1 (compound 1632) is a potent antagonist of Lin28/pre-let-7 interaction. Lin28-let-7 antagonist 1 inhibits Lin28A binding to pre-let-7a-2, with an IC50 of 8 μM. Lin28-let-7 antagonist 1 inhibits proliferation in human cancer cells. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Pubchem Sid | 488192879 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488192879 |
IUPAC Name | N-methyl-N-[3-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]acetamide |
INCHI | InChI=1S/C15H15N5O/c1-10-16-17-15-8-7-14(18-20(10)15)12-5-4-6-13(9-12)19(3)11(2)21/h4-9H,1-3H3 |
InChi Key | WPAQLESUVYGUJZ-UHFFFAOYSA-N |
Canonical SMILES | CC1=NN=C2N1N=C(C=C2)C3=CC(=CC=C3)N(C)C(=O)C |
Isomeric SMILES | CC1=NN=C2N1N=C(C=C2)C3=CC(=CC=C3)N(C)C(=O)C |
PubChem CID | 2737312 |
Molecular Weight | 281.31 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
D2325541 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325549 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325550 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325552 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325553 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325554 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325555 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325559 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325560 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325561 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325563 | Certificate of Analysis | Mar 25, 2023 | L287258 |
D2325564 | Certificate of Analysis | Mar 25, 2023 | L287258 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 28.13, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 28.13, Max Conc. mM: 100 |
---|